ID   ZR-75-27
AC   CVCL_5612
DR   Wikidata; Q54996118
RX   PubMed=obviouslyfakeid;
RX   DOI=obviouslyfakedoi;
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=688225;
CC   Doubling time: 144 hours, at 14th passage (PubMed=688225).
CC   Derived from metastatic site: Pleural effusion.
DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX   NCBI_TaxID=9606; ! Homo sapiens
OI   CVCL_1661 ! ZR-75-30
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-07-19; Version: 12
//
ID   ZR-75-30
AC   CVCL_1661
SY   ZR75-30; ZR7530
DR   BTO; BTO:0004915
DR   CLO; CLO_0009728
DR   EFO; EFO_0001263
DR   CLDB; cl4822
DR   Cosmic; 904399
DR   Wikidata; Q54996119
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=688225;
RX   PubMed=3335022;
RX   PubMed=11044355;
RX   PubMed=11414198;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23151021;
RX   PubMed=23260012;
RX   PubMed=23601657;
RX   PubMed=24009699;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=23260012;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/ZR-75-30.html
WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   http://tcpaportal.org/mclp/
WW   http://www.cellresource.cn/fdetail.aspx?id=240
WW   http://www.cellresource.cn/fdetail.aspx?id=628
WW   http://www.cellresource.cn/fdetail.aspx?id=821
WW   http://www.cellresource.cn/fdetail.aspx?id=1584
WW   http://www.cellresource.cn/fdetail.aspx?id=2096
CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.
ST   Source(s): ATCC; CCRID; Cosmic-CLP; ECACC; PubMed=25877200
DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX   NCBI_TaxID=9606; ! Homo sapiens
OI   CVCL_5612 ! ZR-75-27
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-19; Version: 31
//
ID   ZR-75-9a1
AC   CVCL_5613
DR   Wikidata; Q54996121
RX   PubMed=2713239;
CC   Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.
DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 06-09-19; Version: 13
//
ID   ZR-75-B
AC   CVCL_5614
SY   ZR75-B; ZR-75B; ZR-75b; ZR75B
DR   EFO; EFO_0001264
DR   ArrayExpress; E-TABM-157
DR   Wikidata; Q54996122
RX   PubMed=6178756;
RX   PubMed=17157791;
RX   PubMed=18516279;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25960936;
WW   https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: GrayJW Breast Cancer Cell Line Panel.
DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 06-09-19; Version: 19
//
